HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Inoue Selected Research

Octamer Transcription Factor-1

10/2021OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.
11/2019Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer.
1/2019Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Inoue Research Topics

Disease

182Neoplasms (Cancer)
12/2022 - 02/2002
66Prostatic Neoplasms (Prostate Cancer)
12/2022 - 09/2003
54Breast Neoplasms (Breast Cancer)
02/2022 - 06/2002
22Osteoporosis
06/2021 - 11/2002
20Urinary Bladder Neoplasms (Bladder Cancer)
02/2021 - 01/2015
18Rabies (Hydrophobia)
02/2022 - 08/2003
18Carcinogenesis
01/2022 - 05/2006
13Infections
07/2022 - 09/2003
12Carcinoma (Carcinomatosis)
07/2022 - 10/2005
10Neoplasm Metastasis (Metastasis)
01/2021 - 10/2005
10Brain Neoplasms (Brain Tumor)
01/2019 - 02/2007
7Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 04/2004
7Alzheimer Disease (Alzheimer's Disease)
01/2022 - 10/2010
7Inflammation (Inflammations)
01/2021 - 01/2008
7Glioma (Gliomas)
07/2015 - 10/2010
6Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2016
6Hypoxia (Hypoxemia)
01/2021 - 03/2006
6Hemorrhage
06/2020 - 01/2014
6Sepsis (Septicemia)
01/2018 - 02/2009
6Macular Degeneration (Age-Related Maculopathy)
01/2017 - 06/2010
6Melanoma (Melanoma, Malignant)
11/2007 - 02/2005
5Neuroblastoma
02/2022 - 07/2011
5Endometrial Neoplasms (Endometrial Cancer)
01/2021 - 10/2005
5Disease Progression
01/2020 - 04/2013
5Delirium
08/2015 - 02/2002
4Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 05/2005
4Stomach Neoplasms (Stomach Cancer)
01/2021 - 10/2005
4Wounds and Injuries (Trauma)
09/2020 - 08/2016
4Disseminated Intravascular Coagulation
09/2017 - 05/2013
4Lung Neoplasms (Lung Cancer)
05/2015 - 02/2005
4Necrosis
05/2012 - 08/2002
4Metabolic Bone Diseases (Osteopenia)
12/2010 - 01/2003

Drug/Important Bio-Agent (IBA)

55Proteins (Proteins, Gene)FDA Link
07/2022 - 11/2002
50Androgen Receptors (Androgen Receptor)IBA
12/2022 - 01/2008
46Estrogens (Estrogen)FDA Link
01/2022 - 11/2002
43AndrogensIBA
12/2022 - 12/2004
37Hormones (Hormone)IBA
01/2022 - 11/2004
31Estrogen ReceptorsIBA
02/2022 - 11/2002
22Small Interfering RNA (siRNA)IBA
02/2022 - 05/2005
20Transcription Factors (Transcription Factor)IBA
01/2021 - 09/2008
19Messenger RNA (mRNA)IBA
07/2020 - 05/2003
14RNA (Ribonucleic Acid)IBA
01/2022 - 08/2013
12TamoxifenFDA LinkGeneric
01/2022 - 01/2011
12Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2005
11Pharmaceutical PreparationsIBA
11/2018 - 02/2005
10Biological ProductsIBA
03/2020 - 05/2007
10LigandsIBA
01/2020 - 07/2006
9SteroidsIBA
07/2022 - 11/2004
9AntigensIBA
11/2020 - 08/2003
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 10/2005
9Estrogen Receptor alphaIBA
10/2011 - 03/2003
8Indicators and Reagents (Reagents)IBA
08/2021 - 09/2003
8MicroRNAs (MicroRNA)IBA
01/2021 - 01/2013
8Monoclonal AntibodiesIBA
03/2020 - 02/2007
8AntibodiesIBA
03/2019 - 08/2003
8CytokinesIBA
01/2017 - 11/2002
7Long Noncoding RNAIBA
10/2021 - 06/2013
7Forkhead Transcription Factors (Forkhead Box Proteins)IBA
12/2016 - 09/2008
7Antisense OligonucleotidesIBA
06/2014 - 06/2003
6Vitamin KFDA Link
01/2022 - 05/2005
6Neutralizing AntibodiesIBA
01/2021 - 01/2004
6ChromatinIBA
01/2021 - 12/2004
6EnzymesIBA
10/2020 - 05/2003
6Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2020 - 01/2008
6Progesterone Receptors (Progesterone Receptor)IBA
12/2019 - 10/2011
6poly(malic acid)IBA
09/2015 - 10/2010
5Protein Isoforms (Isoforms)IBA
02/2022 - 12/2004
5RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2022 - 01/2017
5ParaffinIBA
12/2021 - 08/2003
5Histones (Histone)IBA
05/2021 - 01/2009
5Cisplatin (Platino)FDA LinkGeneric
02/2021 - 01/2015
5DNA (Deoxyribonucleic Acid)IBA
02/2021 - 09/2003
5Amyloid (Amyloid Fibrils)IBA
11/2019 - 01/2009
5GTP-Binding Proteins (G-Protein)IBA
03/2019 - 04/2005
5ProgesteroneFDA LinkGeneric
11/2015 - 01/2011
5Genetic Markers (Genetic Marker)IBA
08/2010 - 01/2004
4AdiponectinIBA
01/2022 - 07/2014
4Formaldehyde (Formol)FDA Link
12/2021 - 08/2003
4Serine (L-Serine)FDA Link
01/2021 - 05/2004
4Phosphotransferases (Kinase)IBA
01/2021 - 01/2020
4UbiquitinIBA
01/2021 - 06/2003
4hydroxyflutamideIBA
01/2020 - 11/2013
4CarcinogensIBA
01/2020 - 12/2019
4silodosinFDA Link
01/2020 - 01/2015
4GlucocorticoidsIBA
12/2019 - 01/2010
4Opioid Analgesics (Opioids)IBA
06/2018 - 08/2003
4Dacarbazine (DIC)FDA LinkGeneric
09/2017 - 05/2013
4bicalutamide (Casodex)FDA LinkGeneric
01/2017 - 01/2014
4Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2016 - 03/2015
4Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2016 - 12/2004
4malic acid (malate)IBA
12/2013 - 10/2010
4feralIBA
10/2011 - 06/2004
3PhosphoproteinsIBA
02/2022 - 04/2005
3OsteocalcinIBA
01/2022 - 10/2014
3Octamer Transcription Factor-1IBA
10/2021 - 01/2019

Therapy/Procedure

65Therapeutics
12/2022 - 09/2002
20Drug Therapy (Chemotherapy)
01/2022 - 10/2005
18Castration
01/2020 - 05/2012
10Palliative Care (Palliative Therapy)
01/2022 - 08/2003
5Immunotherapy
01/2022 - 10/2019